Webinar Recording
Discussion of Zanubrutinib for Adult Patients with CLL/SLL
Recorded on: February 12, 2025
Join Kirollos S. Hanna, PharmD, BCPS, BCOP, FACCC (Minnesota Oncology), for an in-depth look at zanubrutinib for adult patients with CLL/SLL.
Gain insights into the:
– Pharmacokinetics and pharmacodynamics among BTK inhibitors
– Unique advantages of zanubrutinib and its design to overcome challenges of BTK inhibition
– Key findings from the ALPINE and SEQUOIA studies
– Dosing, safety, pricing, and distribution